Search results
Zacks Research Comments on Bristol-Myers Squibb’s FY2024 Earnings (NYSE:BMY)
ETF DAILY NEWS· 1 day agoBristol-Myers Squibb (NYSE:BMY – Free Report) – Equities research analysts at Zacks Research issued their FY2024 earnings estimates for shares of Bristol-Myers Squibb in a report issued on Thursday ...
Is Bristol Myers' Dividend in Danger?
The Motley Fool via AOL· 4 days agoBristol Myers Squibb (NYSE: BMY) pays investors an attractive dividend, which yields an incredibly high rate of 5.5%. That's nearly four times the S&P...
Bristol Myers Squibb Cancer-Treatment Trial Misses Endpoint
The Wall Street Journal· 5 days agoBristol Myers Squibb said its trial evaluating a combination of cancer treatments failed to meet its...
Nabla Bio secures $26m in Series A funding round
Pharmaceutical Technology via Yahoo Finance· 4 hours agoUS pharmaceutical company Nabla Bio has secured $26m for generative protein design in a Series A financing round led by Radical Ventures. The round...
Cytokinetics Reverses Higher On 'Pristine' Results For Bristol Myers-Rivaling Heart Drug
Investor's Business Daily· 17 hours agoCytokinetics stock reversed higher Tuesday after safety worries clouded promising study results for...
Bristol Myers Squibb reports setback in lung cancer trial By Investing.com
Investing.com· 5 days agoBristol Myers Squibb (NYSE: NYSE:BMY) disclosed that its Phase 3 CheckMate -73L trial for treating a...
Daily Spotlight: Profit Margins Widened in 1Q
Argus Research via Yahoo Finance· 2 hours agoFirst-quarter earnings season is winding down as the retailers wrap up their reports. The overall growth rate is set to land in the 7%-8% range. That's not bad -- and the rate would be higher ...
News Highlights: Top Company News of the Day - Friday at 7 PM ET
Morningstar· 5 days agoBristol Myers Squibb said its trial evaluating a combination of cancer treatments failed to meet its primary endpoint. The television company, which produces "The Walking Dead," cited "declines ...
Insider Buying: BOERNER CHRISTOPHER S., Bristol-Myers Squibb Co. [BMY] Chief Executive Officer...
Knox Daily· 6 days agoThe buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Bristol-Myers Squibb Co. shares valued at $99,560 were purchased ...
Big Pharma layoffs continue, as Bristol-Myers Squibb cuts 2,200 jobs, $1.5B in costs
BenefitsPRO· 5 days agoAt a time when drugmakers Eli Lilly & Co. and Novo Nordisk are scrambling to meet demand for their...
